Alana Harris Dent

Array ( [id] => 4675541 [patent_doc_number] => 20080213170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Cancerous Disease Modifying Antibodies' [patent_app_type] => utility [patent_app_number] => 12/017855 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17292 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213170.pdf [firstpage_image] =>[orig_patent_app_number] => 12017855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6339914 [patent_doc_number] => 20100247520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'MUTATED NETRIN 4, FRAGMENTS THEREOF AND USES THEREOF AS DRUGS' [patent_app_type] => utility [patent_app_number] => 12/523074 [patent_app_country] => US [patent_app_date] => 2008-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21260 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247520.pdf [firstpage_image] =>[orig_patent_app_number] => 12523074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4954907 [patent_doc_number] => 20080187931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Mutations associated with iron disorders' [patent_app_type] => utility [patent_app_number] => 12/005791 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9688 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187931.pdf [firstpage_image] =>[orig_patent_app_number] => 12005791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 91721 [patent_doc_number] => 07732159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples' [patent_app_type] => utility [patent_app_number] => 11/965323 [patent_app_country] => US [patent_app_date] => 2007-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20487 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732159.pdf [firstpage_image] =>[orig_patent_app_number] => 11965323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6430664 [patent_doc_number] => 20100143334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'T-140 PEPTIDE ANALOGS HAVING CXCR4 SUPER-AGONIST ACTIVITY FOR IMMUNOMODULATION' [patent_app_type] => utility [patent_app_number] => 12/520811 [patent_app_country] => US [patent_app_date] => 2007-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20153 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143334.pdf [firstpage_image] =>[orig_patent_app_number] => 12520811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6087711 [patent_doc_number] => 20110217231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'ANTI-TENASCIN MONOCLONAL ANTIBODY THERAPY FOR LYMPHOMA' [patent_app_type] => utility [patent_app_number] => 11/961840 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7734 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217231.pdf [firstpage_image] =>[orig_patent_app_number] => 11961840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6633149 [patent_doc_number] => 20100173426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'BIOMAKER IDENTIFYING THE REACTIVATION OF STAT3 AFTER SRC INHIBITION' [patent_app_type] => utility [patent_app_number] => 12/519848 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14768 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173426.pdf [firstpage_image] =>[orig_patent_app_number] => 12519848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853143 [patent_doc_number] => 20080318886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Methods of Increasing Cancer Sensitivity to Chemotherapeutic Agents Using Chimeric ISF35' [patent_app_type] => utility [patent_app_number] => 11/951254 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8000 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318886.pdf [firstpage_image] =>[orig_patent_app_number] => 11951254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4832818 [patent_doc_number] => 20080131365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 11/938841 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13953 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131365.pdf [firstpage_image] =>[orig_patent_app_number] => 11938841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820473 [patent_doc_number] => 20080226644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Novel cancer associated protein' [patent_app_type] => utility [patent_app_number] => 11/983052 [patent_app_country] => US [patent_app_date] => 2007-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19184 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226644.pdf [firstpage_image] =>[orig_patent_app_number] => 11983052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4547764 [patent_doc_number] => 07960346 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Tumor cytotoxicity induced by modulators of the CXCR4 receptor' [patent_app_type] => utility [patent_app_number] => 11/979492 [patent_app_country] => US [patent_app_date] => 2007-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5762 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960346.pdf [firstpage_image] =>[orig_patent_app_number] => 11979492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4833354 [patent_doc_number] => 20080131901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/980427 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 21806 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131901.pdf [firstpage_image] =>[orig_patent_app_number] => 11980427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820366 [patent_doc_number] => 20080226620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 11/929396 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 88112 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226620.pdf [firstpage_image] =>[orig_patent_app_number] => 11929396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820428 [patent_doc_number] => 20080226633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 11/929595 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46347 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226633.pdf [firstpage_image] =>[orig_patent_app_number] => 11929595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820464 [patent_doc_number] => 20080226642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 11/929624 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46346 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226642.pdf [firstpage_image] =>[orig_patent_app_number] => 11929624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670330 [patent_doc_number] => 20110319599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'MN Gene and Protein' [patent_app_type] => utility [patent_app_number] => 11/930041 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 30181 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11930041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969054 [patent_doc_number] => 20110150882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 11/929614 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46348 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150882.pdf [firstpage_image] =>[orig_patent_app_number] => 11929614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4739471 [patent_doc_number] => 20080233124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 11/929600 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46348 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233124.pdf [firstpage_image] =>[orig_patent_app_number] => 11929600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4959686 [patent_doc_number] => 20080274111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Pancreatic Cancer Genes' [patent_app_type] => utility [patent_app_number] => 11/929965 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10143 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274111.pdf [firstpage_image] =>[orig_patent_app_number] => 11929965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5484853 [patent_doc_number] => 20090274618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'TADG-15: an extracellular serine protease overexpressed in carcinomas' [patent_app_type] => utility [patent_app_number] => 11/978259 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 14405 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274618.pdf [firstpage_image] =>[orig_patent_app_number] => 11978259 [rel_patent_id] =>[rel_patent_doc_number] =>)